Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

People using GLP-1 medications are more likely to suffer severe acid reflux, a new study suggests. Researchers found patients ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

KATIE Price has revealed her son Harvey now weighs 30st, as she gave fans an update on him taking weight loss jabs. The ...

A MOTHER has managed to shift over three stone thanks to Mounjaro, but has revealed the five things she wishes she had known ...

IN 1971 RICHARD NIXON, then America’s president, announced a “war on cancer". Just two years earlier the Apollo programme had ...